Lyrica (pregabalin) most commonly causes dizziness, drowsiness, and weight gain. In clinical trials, dizziness affected up to 30% of people taking the drug, making it the single most reported side effect. Most side effects are dose-related, meaning they become more likely and more intense at higher doses, and many improve over the first few weeks of treatment.
Lyrica works by binding to a specific part of calcium channels in the nervous system, which reduces the release of certain chemical messengers between nerve cells. This calms overactive nerve signaling, which is why it helps with nerve pain, seizures, and fibromyalgia. But that same calming effect on the nervous system is also what produces most of the side effects people experience.
The Most Common Side Effects
The side effects you’re most likely to notice are ones that affect your brain and energy levels. In controlled trials, these were the most frequently reported:
- Dizziness: 30% of people taking Lyrica, compared to 8% on placebo
- Drowsiness: 23% on Lyrica vs. 8% on placebo
- Nausea: around 22% in some trials
- Headache: roughly 19%, though this was similar to placebo rates
- Fatigue: about 15%
- Dry mouth, blurred vision, and difficulty concentrating each affected at least 5% of people in trials
Dizziness and drowsiness typically begin shortly after starting the medication. For many people, these ease up as the body adjusts over a couple of weeks. If they don’t, a lower dose often helps, since both side effects track closely with how much you’re taking.
How Dose Affects Dizziness and Drowsiness
The relationship between dose and these two side effects is steep. Clinical trial data for diabetic nerve pain shows dizziness in 8% of people at 75 mg per day, jumping to 29% at 600 mg per day. Drowsiness follows the same pattern: 4% at the lowest dose, 16% at the highest.
The numbers are even more striking for fibromyalgia patients. At 150 mg daily, 23% reported dizziness. At 600 mg daily, that climbed to 45%, nearly half of all participants. This is why most prescribers start Lyrica at a low dose and increase gradually. If you’re experiencing significant dizziness or sedation, it’s worth discussing whether your current dose is the right one.
Weight Gain
Weight gain is one of the side effects people find most frustrating because it tends to be persistent rather than temporary. In 14-week studies, about 9% of people taking Lyrica gained at least 7% of their starting body weight, compared to just 2% on placebo. For someone weighing 170 pounds, that’s roughly 12 pounds or more.
The effect becomes more pronounced over time. In a group of 333 people with diabetes who took Lyrica for at least two years, the average weight gain was about 11.4 pounds. People with diabetes in shorter trials gained an average of 3.5 pounds, compared to less than a pound in the placebo group. The weight gain isn’t fully understood, but it likely involves both increased appetite and fluid retention.
Swelling in the Hands and Feet
Peripheral edema, or swelling in the lower legs, ankles, and feet, is a well-known effect of Lyrica. Depending on the dose, it occurs in up to 16% of people taking the drug, compared to 2% to 5% on placebo. A meta-analysis found that people on pregabalin were about 2.6 times more likely to develop this kind of swelling than those on placebo.
For most people, this swelling is uncomfortable but not dangerous. However, for anyone with heart failure, the picture is different. The American Heart Association lists pregabalin among medications that may worsen underlying heart dysfunction. The FDA advises caution in people with more advanced heart failure (NYHA class III or IV), because the drug’s effect on calcium channels could potentially reduce the heart’s pumping ability, similar to certain blood pressure medications that are avoided in heart failure.
Serious but Rare Side Effects
A small number of people experience allergic reactions that require immediate attention. Post-marketing reports describe angioedema, which is swelling of the face, tongue, lips, or throat. Some cases involved the airway and required emergency treatment. If you notice swelling in your face or throat after starting Lyrica, this is not something to wait out.
Other hypersensitivity reactions include skin redness, hives, blisters, rash, and difficulty breathing. These tend to appear shortly after starting the medication.
Like all anti-seizure medications, Lyrica carries a warning about suicidal thoughts and behavior. In pooled data from 199 placebo-controlled trials of various anti-seizure drugs, people taking these medications had roughly twice the risk of suicidal thinking compared to those on placebo, at 0.43% versus 0.24%. That’s about one additional case for every 530 people treated. The risk appeared as early as one week after starting treatment. This doesn’t mean Lyrica commonly causes suicidal thoughts, but it’s important to be aware of mood changes, especially in the early weeks.
Interactions With Opioids and Other Sedatives
One of the most serious risks with Lyrica isn’t from the drug alone but from combining it with other substances that depress the central nervous system. Taking Lyrica with opioids, benzodiazepines, or alcohol has been linked to respiratory failure, coma, and deaths.
The risk is particularly elevated at higher doses. Studies show that pregabalin doses over 300 mg per day combined with opioids are especially associated with increased risk of opioid-related death. In UK safety reports collected over a seven-year period, 122 cases of respiratory depression were reported with pregabalin, and 80 of those involved a co-administered sedating medication like an opioid or benzodiazepine. If you take Lyrica alongside any of these substances, the sedation and breathing suppression from each drug amplifies the other.
Dependence and Withdrawal
Lyrica can produce physical dependence, meaning your body adapts to the drug over time and reacts when it’s removed. This doesn’t happen to everyone, but it’s common enough that abrupt discontinuation is not recommended. When stopping Lyrica, the standard approach is to reduce the daily dose by no more than 50 to 100 mg per week, tapering gradually over at least a week and sometimes longer.
Withdrawal symptoms can include insomnia, headache, nausea, anxiety, diarrhea, and a return or worsening of the symptoms Lyrica was treating. A slower taper allows your prescriber to distinguish between true withdrawal and the re-emergence of your underlying condition. If you’ve been on Lyrica for months or longer, expect the tapering process to take several weeks rather than days.
What Tends to Improve and What Doesn’t
Many of Lyrica’s neurological side effects, particularly dizziness, drowsiness, and blurred vision, tend to resolve or lessen over the first few weeks as your body adjusts. Clinical data notes that signs of central nervous system depression were generally seen at doses higher than those needed for therapeutic benefit, which means there’s often a sweet spot where the drug works without overwhelming side effects.
Weight gain and edema, on the other hand, tend to be more persistent. Weight gain in particular can continue accumulating over months and years of use rather than plateauing early. This makes it worth tracking your weight periodically if you’re on Lyrica long-term, so you and your prescriber can make informed decisions about whether the benefits continue to outweigh the downsides.